BR9902245A - Espiro [piperidina-4,1'-pirrolo[3,4-c]pirrol] - Google Patents
Espiro [piperidina-4,1'-pirrolo[3,4-c]pirrol]Info
- Publication number
- BR9902245A BR9902245A BR9902245A BR9902245A BR9902245A BR 9902245 A BR9902245 A BR 9902245A BR 9902245 A BR9902245 A BR 9902245A BR 9902245 A BR9902245 A BR 9902245A BR 9902245 A BR9902245 A BR 9902245A
- Authority
- BR
- Brazil
- Prior art keywords
- pyrrole
- disorders
- spiro
- piperidine
- orphanage
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
ROLO[3,4-C] PIRROL]". A presente invenção se refere a compostos da fórmula geral em que os substituintes são descritos no relatório e a seus sais de aposto da invenção é útil no tratamento de doenças relacionadas com o receptor de orfanina FQ (OFQ), que incluem desordens neurológicas e fisiólogicas,ão, trauma, perda de memória devido a doença de Alzheimer ou outras demências, déficits em aprendizas de dor aguda e/ou crónica, e sintomas de retirada de droga viciadora, controle do equilíbrio de água, excreções de Na^ +^ , desordens de pressão de sangue arterial e desordens metabólicas tal como obesidade.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98110803 | 1998-06-12 | ||
| EP98124119 | 1998-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9902245A true BR9902245A (pt) | 2000-03-21 |
Family
ID=26149342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9902245A BR9902245A (pt) | 1998-06-12 | 1999-06-11 | Espiro [piperidina-4,1'-pirrolo[3,4-c]pirrol] |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6075034A (pt) |
| EP (1) | EP0963987B1 (pt) |
| JP (1) | JP3308507B2 (pt) |
| KR (1) | KR100346607B1 (pt) |
| AR (1) | AR018650A1 (pt) |
| AT (1) | ATE222908T1 (pt) |
| AU (1) | AU749995B2 (pt) |
| BR (1) | BR9902245A (pt) |
| CA (1) | CA2274204C (pt) |
| CO (1) | CO5060459A1 (pt) |
| DE (1) | DE69902606T2 (pt) |
| DK (1) | DK0963987T3 (pt) |
| ES (1) | ES2181336T3 (pt) |
| HR (1) | HRP990189A2 (pt) |
| HU (1) | HUP9901909A3 (pt) |
| ID (1) | ID23283A (pt) |
| IL (1) | IL130376A0 (pt) |
| MA (1) | MA26643A1 (pt) |
| NO (1) | NO312069B1 (pt) |
| NZ (1) | NZ336186A (pt) |
| PE (1) | PE20000549A1 (pt) |
| PL (1) | PL333694A1 (pt) |
| PT (1) | PT963987E (pt) |
| SG (1) | SG76623A1 (pt) |
| TR (1) | TR199901304A2 (pt) |
| TW (1) | TW523516B (pt) |
| YU (1) | YU26599A (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6969712B2 (en) | 2000-11-15 | 2005-11-29 | Banyu Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
| JP2005502619A (ja) * | 2001-07-02 | 2005-01-27 | オメロス コーポレイション | オピオイドレセプター様レセプター１アゴニストと交替でオピオイドレセプターアゴニストを投与することを含む、痛覚脱失を生成するための方法 |
| US20030040479A1 (en) * | 2001-07-02 | 2003-02-27 | Omeros Corporation | Rotational intrathecal analgesia method and device |
| JP2005289816A (ja) | 2002-05-14 | 2005-10-20 | Banyu Pharmaceut Co Ltd | ベンズイミダゾール誘導体 |
| ZA200510329B (en) * | 2003-05-23 | 2007-04-25 | Zealand Pharma As | Triaza-spiro compounds as nociceptin analogues and uses thereof |
| US20050228023A1 (en) * | 2003-12-19 | 2005-10-13 | Sri International | Agonist and antagonist ligands of the nociceptin receptor |
| JP4446978B2 (ja) * | 2006-04-28 | 2010-04-07 | トヨタ自動車株式会社 | 車両用駆動力制御装置 |
| JP5313865B2 (ja) * | 2007-03-01 | 2013-10-09 | 田辺三菱製薬株式会社 | ベンゾイミダゾール化合物およびその医薬用途 |
| KR101561666B1 (ko) | 2014-08-12 | 2015-10-20 | 최인석 | 골프 퍼팅 교정장치 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534520A (en) * | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
| CA2226058C (en) * | 1997-01-30 | 2008-01-29 | F. Hoffmann-La Roche Ag | 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
-
1999
- 1999-06-07 DK DK99110944T patent/DK0963987T3/da active
- 1999-06-07 AT AT99110944T patent/ATE222908T1/de active
- 1999-06-07 ES ES99110944T patent/ES2181336T3/es not_active Expired - Lifetime
- 1999-06-07 DE DE69902606T patent/DE69902606T2/de not_active Expired - Lifetime
- 1999-06-07 PT PT99110944T patent/PT963987E/pt unknown
- 1999-06-07 EP EP99110944A patent/EP0963987B1/en not_active Expired - Lifetime
- 1999-06-08 PE PE1999000485A patent/PE20000549A1/es not_active Application Discontinuation
- 1999-06-09 CO CO99036175A patent/CO5060459A1/es unknown
- 1999-06-09 HU HU9901909A patent/HUP9901909A3/hu unknown
- 1999-06-09 NZ NZ336186A patent/NZ336186A/xx unknown
- 1999-06-09 SG SG1999002779A patent/SG76623A1/en unknown
- 1999-06-09 CA CA002274204A patent/CA2274204C/en not_active Expired - Fee Related
- 1999-06-09 IL IL13037699A patent/IL130376A0/xx unknown
- 1999-06-10 YU YU26599A patent/YU26599A/sh unknown
- 1999-06-10 TR TR1999/01304A patent/TR199901304A2/xx unknown
- 1999-06-10 JP JP16397599A patent/JP3308507B2/ja not_active Expired - Fee Related
- 1999-06-10 MA MA25615A patent/MA26643A1/fr unknown
- 1999-06-10 AR ARP990102765A patent/AR018650A1/es active IP Right Grant
- 1999-06-10 KR KR1019990021570A patent/KR100346607B1/ko not_active IP Right Cessation
- 1999-06-11 PL PL99333694A patent/PL333694A1/xx unknown
- 1999-06-11 AU AU35003/99A patent/AU749995B2/en not_active Ceased
- 1999-06-11 BR BR9902245A patent/BR9902245A/pt not_active Application Discontinuation
- 1999-06-11 HR HR98124119.3A patent/HRP990189A2/hr not_active Application Discontinuation
- 1999-06-11 US US09/330,857 patent/US6075034A/en not_active Expired - Fee Related
- 1999-06-11 NO NO19992872A patent/NO312069B1/no unknown
- 1999-06-14 ID IDP990577A patent/ID23283A/id unknown
- 1999-06-21 TW TW088110336A patent/TW523516B/zh active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104379574B (zh) | 用于抑制abl1、abl2和bcr‑abl1的活性的苯甲酰胺衍生物 | |
| BRPI0313694B8 (pt) | derivados de pirazol, composição medicinal contendo os mesmos, seu uso medicinal e intermediários para sua produção | |
| BR0312549A (pt) | Derivados de indolin-fenilsulfonamida | |
| BR9902245A (pt) | Espiro [piperidina-4,1'-pirrolo[3,4-c]pirrol] | |
| BRPI0412900A (pt) | cianopirrolididas, processo para a sua preparação e seu emprego como medicamento | |
| BR0211053A (pt) | Derivados 1-oxa-2,8-diaza-spiro [4,5] dec-2-en substituìdos como medicamentos para o tratamento de dor | |
| CN104302634A (zh) | 用于抑制abl1、abl2和bcr-abl1的活性的苯甲酰胺衍生物 | |
| BRPI0415863A (pt) | derivados pirazina e seus usos farmacêuticos | |
| CN104583213A (zh) | 取代的吡啶唑并嘧啶-5-(6h)-酮化合物 | |
| MXPA04005444A (es) | Ureas de 2-aminobenzotiazoles como moduladores de adenosina. | |
| TR200001669T2 (tr) | Piperidin türevleri. | |
| NO984081L (no) | Pyrimido[5,4-d]pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremtilling derav | |
| BRPI0407253A (pt) | Heterociclil-3-sulfonilindazóis como ligandos 5-hidroxitriptamina-6 processo de preparação dos mesmos, seus usos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os referidos compostos | |
| CN105873921A (zh) | 苯并咪唑-脯氨酸衍生物的用途 | |
| CN101530647B (zh) | 经颅磁电抑郁症治疗仪 | |
| BR9805297A (pt) | Derivados de 1,3,8-triazaspiro (4,5) decan-4on. | |
| DE4394931T1 (de) | Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen | |
| MY188367A (en) | Crystalline forms glyt1 | |
| ATE366581T1 (de) | Apoptotische körper zur verwendung in der behandlung von neurodegenerativen und sonstigen nervenerkrankungen | |
| CN104127441B (zh) | 抗眼疲劳的滴眼液及其制备方法 | |
| DK261289D0 (da) | Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser | |
| TW200510331A (en) | Heteroaryl-substituted imidazole derivatives | |
| Feldman et al. | Integrating physical therapy with behavior therapy: a case study | |
| WO2005102316A3 (en) | Use of coumarin derivatives | |
| EP1698697A3 (en) | SSD-containing protein, process for producing the same and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |